Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics (Q39408230)
Jump to navigation
Jump to search
scientific article published on April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics |
scientific article published on April 2002 |
Statements
1 reference
Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics (English)
1 reference
Michael A Carducci
1 reference
Joel B Nelson
1 reference
M Kathy Bowling
1 reference
Theresa Rogers
1 reference
Mario A Eisenberger
1 reference
Victoria Sinibaldi
1 reference
Ross Donehower
1 reference
Terri L Leahy
1 reference
Robert A Carr
1 reference
Jeffrey D Isaacson
1 reference
Todd J Janus
1 reference
Amy Andre
1 reference
Balakrishna S Hosmane
1 reference
Robert J Padley
1 reference
1 April 2002
1 reference
1 reference
20
1 reference
8
1 reference
2171-2180
1 reference
Identifiers
1 reference
1 reference